Literature DB >> 21223428

SIV-specific CD8+ T cells are enriched in female genital mucosa of rhesus macaques and express receptors for inflammatory chemokines.

Mandy A Cromwell1, Angela Carville, Keith Mansfield, Sherry Klumpp, Susan V Westmoreland, Andrew A Lackner, R Paul Johnson.   

Abstract

PROBLEM: Mucosal T lymphocyte responses in the female reproductive tract, the primary site of HIV transmission in women, may be critical for initial control of virus infection. In addition, characterization of genital immune responses to HIV will be important for the development of a vaccine capable of preventing infection by this route. METHOD OF STUDY: We analyzed lymphocytes isolated from vagina and cervix of chronically SIV-infected macaques for the frequency of SIV Gag tetramer-binding cells and expression of chemokine receptors.
RESULTS: We found that the frequency of SIV-specific CD8+ T cell responses was 3- to 30-fold higher in genital tissues than in peripheral blood. SIV-specific CD8+ T cells in genital tissues expressed high levels of CXCR3 and CCR5, chemokine receptors normally expressed on memory T cells that home to inflamed tissues. Cells expressing CXCR3 colocalized with its chemokine ligand CXCL9 [monokine induced by interferon gamma, MIG] in the vaginal lamina propria.
CONCLUSION: These results indicate that the frequency of SIV-specific CD8+ T cells in the female genital mucosa is enriched compared with peripheral blood and provide initial information regarding the signals that direct recruitment of T cells to the female reproductive tract.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21223428      PMCID: PMC3076015          DOI: 10.1111/j.1600-0897.2010.00966.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  16 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

Review 2.  T-cell function and migration. Two sides of the same coin.

Authors:  U H von Andrian; C R Mackay
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

3.  CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection.

Authors:  R Keith Reeves; Jacqueline Gillis; Fay E Wong; Yi Yu; Michelle Connole; R Paul Johnson
Journal:  Blood       Date:  2010-03-25       Impact factor: 22.113

4.  Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques.

Authors:  Ussama M Abdel-Motal; Jacqueline Gillis; Kelledy Manson; Michael Wyand; David Montefiori; Kelly Stefano-Cole; Ronald C Montelaro; John D Altman; R Paul Johnson
Journal:  Virology       Date:  2005-03-15       Impact factor: 3.616

5.  Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus.

Authors:  M A Cromwell; R S Veazey; J D Altman; K G Mansfield; R Glickman; T M Allen; D I Watkins; A A Lackner; R P Johnson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells.

Authors:  J Hu; M B Gardner; C J Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys.

Authors:  M Genescà; P J Skinner; K M Bost; D Lu; Y Wang; T L Rourke; A T Haase; M B McChesney; C J Miller
Journal:  Mucosal Immunol       Date:  2008-03-05       Impact factor: 7.313

8.  Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.

Authors:  T M Allen; J Sidney; M F del Guercio; R L Glickman; G L Lensmeyer; D A Wiebe; R DeMars; C D Pauza; R P Johnson; A Sette; D I Watkins
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

9.  HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages.

Authors:  S Swingler; A Mann; J Jacqué; B Brichacek; V G Sasseville; K Williams; A A Lackner; E N Janoff; R Wang; D Fisher; M Stevenson
Journal:  Nat Med       Date:  1999-09       Impact factor: 87.241

10.  Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection.

Authors:  A Cerwenka; T M Morgan; A G Harmsen; R W Dutton
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

View more
  4 in total

Review 1.  Tissue-resident memory T cells.

Authors:  Jason M Schenkel; David Masopust
Journal:  Immunity       Date:  2014-12-06       Impact factor: 31.745

2.  T Cells in the Female Reproductive Tract Can Both Block and Facilitate HIV Transmission.

Authors:  Christopher J Miller; Ronald S Veazey
Journal:  Curr Immunol Rev       Date:  2019

3.  Differences in Vaginal Microbiota, Host Transcriptome, and Proteins in Women With Bacterial Vaginosis Are Associated With Metronidazole Treatment Response.

Authors:  Joyce Serebrenik; Tao Wang; Richard Hunte; Sujatha Srinivasan; Jessica McWalters; Gregory K Tharp; Steven E Bosinger; Tina L Fiedler; Jessica M Atrio; Kerry Murphy; Rebecca Barnett; Laurie R Ray; Meighan L Krows; David N Fredricks; Elizabeth Irungu; Kenneth Ngure; Nelly Mugo; Jeanne Marrazzo; Marla J Keller; Betsy C Herold
Journal:  J Infect Dis       Date:  2021-12-15       Impact factor: 5.226

4.  The magnitude and kinetics of the mucosal HIV-specific CD8+ T lymphocyte response and virus RNA load in breast milk.

Authors:  Tatenda Mahlokozera; Helen H Kang; Nilu Goonetilleke; Andrea R Stacey; Rachel V Lovingood; Thomas N Denny; Linda Kalilani; James E G Bunn; Steve R Meshnick; Persephone Borrow; Norman L Letvin; Sallie R Permar
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.